Product Information
CYCLOBENZAPRINE ER 15 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.2901 per EA under NDC 00115143613. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115143613
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021777On Market Since
3/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE ER 15 MG CAP has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2901 per EA |
|---|---|
| All-time high | $2.4297 (Nov 13, 2024) |
| All-time low | $1.0384 (Apr 23, 2025) |
| 52-week high | $1.3365 |
| 52-week low | $1.0795 |
| Median price | $1.2901 |
| Average price | $1.5341 |
| Largest weekly change | +45.1% (May 22, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE ER 15 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.2901 per EA (NDC 00115143613), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE ER 15 MG CAP has declined 13.3%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE ER 15 MG CAP?
Since Apr 17, 2024, the NADAC for CYCLOBENZAPRINE ER 15 MG CAP has ranged from a low of $1.0384 (Apr 23, 2025) to a high of $2.4297 (Nov 13, 2024), with a median of $1.2901 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE ER 15 MG CAP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE ER 15 MG CAP, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE ER 15 MG CAP?
CYCLOBENZAPRINE ER 15 MG CAP (NDC 00115143613) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification